Liver iron influences the response to interferon alpha therapy in chronic hepatitis C

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 5, 1997, Pages 497-503

  Fargion, Silvia ^a,d   Ludovica Fracanzani, Anna ^a   Sampietro, Maurizio ^a   Molteni, Virginio ^a   Boldorini, Renzo ^b   Mattioli, Michela ^a   Cesana, Bruno ^c   Lunghi, Giovanna ^c   Piperno, Alberto ^a   Valsecchi, Carla ^a   Fiorelli, Gemino ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b University of Novara   (Italy)

^c Epidemiological Unit   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Cellular iron distribution; Chronic hepatitis C; Interferon; Liver iron concentration

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IRON; TRANSFERRIN; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENOTYPE; HEPATITIS C; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER BIOPSY; LIVER LEVEL; LIVER SINUSOID; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHLEBOTOMY; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 8244248790     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199705000-00016     Document Type: Article

References (39)

1. Koretz RL, Stone O, Mousa M: The NANB post-transfusion hepatitis. A decade later. Gastroenterology 1985, 88:1251-1254.
2. Di Bisceglie AM, Martin P, Kassianides C, et al.: Recombinant interferon alpha therapy for chronic hepatitis. N Engl J Med 1989, 321:1506-1510.
3. Davis GL, Balardt LA, Schiff ER, et al.: Treatment for chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989, 321:1501-1506.
4. Iino S, Hino K, Kuroki T, et al.: Treatment of chronic hepatitis C with high dose alpha-interferon-2b: a multicenter study. Dig Dis Sci 1993, 38:612-618.
5. Shindo M, Di Bisceglie AM, Hoofnagle JH: Long term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology 1992, 15:1013-1016.
6. Hagiwara H, Hayashi N, Mita E, et al.: Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993, 104:877-883.
7. Serfaty L, Giral P, Loria A, et al.: Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 1994, 21:12-17.
8. Pagliaro L, Craxi A, Cammaà C, et al.: Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 1994, 19:820-828.
9. Hino K, Sainokami S, Shimoda K, et al.: Genotypes and liters of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994, 42:299-305.
10. Chemello L, Bonetti P, Cavalletto L, et al.: Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 1995, 22:700-706.
11. Martinot-Peignoux M, Marcellin P, Pouteau M, et al.: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995, 22:1050-1056.
12. Conjeevaram HS, Everhart JE, Hoofnagle JH: Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995, 22:1326-1329.
13. Van Thiel DH, Friedlander L, Fagiuoli S, et al.: Response to interferon a therapy is influenced by the iron content of the liver. J Hepatol 1994, 20:410-415.
14. Olynyk JK, Reddy KR, Di Bisceglie AM, et al.: Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995, 108:1104-1109.
15. Piperno A, Sampietro M, D'Alba R, et al.: Iron stores, response to a-interferon therapy and effects of iron depletion in chronic hepatitis C. Liver 1996, 16:248-254.
16. Barton AL, Banner BF, Cable EE, et al.: Distribution of iron in the liver predicts the response of chronic hepatic C infection to irtterferon therapy. Am J Clin Pathol 1995, 103:419-424.
17. Deugnier YM, Loreal O, Turlin B, et al.: Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlation. Gastroenterology 1992, 102:2050-2059.
18. Sampietro M, Salvadori S, Corbetta N, et al: Single-tube reverse transcription and heminested polymerase chain reaction of hepatitis C virus RNA to detect viremia in serologically negative hemodialysis patients, Int J Clin Lab Res 1995, 25:52-54.
19. McOmish F, Chan SW, Dow BC, et al.: Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993, 33:7-21.
20. Simmonds P, Alberti A, Alter HJ, et al.: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994, 19:1321-1324.
21. Barry M, Sherlock S: Measurement of liver iron concentration in needle biopsy specimens. Lancet 1971, i:100-103.
22. Rappaport AM, Borowy ZJ, Lougheed WM, et al.: Subdivision of hexagonal liver lobules into a structural and functional unit, role of hepatic physiology and pathology. Anat Rec 1954, 119:11-34.
23. Knodell RG, Ishak KG, Black WC, et al.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
24. Desmet WJ: Histopathology of chronic hepatitis. In Chronic Hepatitis. Edited by Liaw Y-P. Amsterdam: Elsevier Science Publishers; 1986:27-44.
25. Carreno V with the International Hepatitis Study Group and Wolfe L with the HCV PCR Diagnostic Group: Genotype dependent response to interferon a-2a in patients with chronic hepatitis C [abstract]. Hepatology 1995, 22:176A.
26. Armitage P, Berry G: Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications; 1987.
27. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York: J Wiley & Sons; 1989.
28. Isomura T, Yano M, Hayashi H, et al: Excess iron in the liver of patients with chronic hepatitis C. J Clin Electron Microscopy 1992, 25:231-237.
29. Di Bisceglie AM, Axiotis CA, Hofnagle JH, et al.: Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992, 102:2108-2113.
30. Hayashi H, Takikawa T, Nishimura N, et al.: Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Castroenterol 1994, 89:986-988.
31. Hayashi H, Takikawa T, Nishimura N, et al.: Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol 1995, 22:268-271.
32. Piperno A, D'Alba R, Fargion S, et al: Liver iron concentration in chronic viral hepatitis: a study of 98 patients, Eur J Gastroenterol Hepatol 1995, 7:1203-1208.
33. Simons IN, Leary TP, Dawson GJ, et al: Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995, 6:1-6.
34. Misokami M, Lau JY, Suzuki K, et al.: Differential sensitivity of hepatitis C virus quasispecies to interferon-a therapy. J Hepatol 1994, 21:884-886.
35. Pietrangelo A, Gualdi R, Casalgrandi G, et al.: Iron overload in rodents leads to hepatic cirrhosis through enhancement of collagen gene expression into non-parenchymal cells. In Fatstoring Cells and Liver Fibrosis. Edited by Surrenti C, Casini A, Milani S et al. Dordrecht, Boston, London: Kluwer Academic Publishers; 1994:250-254.
36. Tilg H, Wilmer A, Vogel W, et al.: Serum levels of cytokines in chronic liver disease. Gastroenterology 1992, 103:264-274.
37. Kaji K, Nakanuma Y, Sasaki M, et al.: Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum Pathol 1995, 26:1080-1085.
38. Adams DH, Hubeher SG, Shaw J, et al.: Increased expression of intracellular adhesion molecule on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991, 14:426-431.
39. Yoshioka K, Kakumu S, Wakita T, et al.: Detection of hepatitis C virus by polymerase chain reaction and response to interferonalpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992, 16:293-299.